Clinical and translational attributes of immune-related adverse events

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.7K citations · Full text

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson, Justin M. Balko, Margaret Compton et al. · New England Journal of Medicine · 2016 · 2.2K citations · Full text

Fatal Myocarditis, Cancer Immunosurveillance, Skeletal Muscle +12

Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice

Hiroyuki Nishimura, Taku Okazaki, Yoshimasa Tanaka et al. · Science · 2001 · 1.8K citations

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Journal of Clinical Oncology · 2021 · 1.7K citations · Full text

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

New England Journal of Medicine · 2022 · 1.6K citations · Full text